Back to top
Back to top
This company has previously raised $75,000 from accredited investors.
Raised to Date

Issue Type:
Convertible Note
8% annual interest rate; maturity date is 24 months after closing. Terms subject to full offering documents.
Accredited Only:
Reviewed Financials:
Price per Unit:
Minimum Investment:
Requested Investment:
Investment Increments:
Minimum Goal:
Target Goal:
Maximum Goal:
Raise Start Date:
April 11th, 2023
Raise Target Date:
August 31st, 2023
Raise End Date:
April 6th, 2024
* Previously Raised:

There is an information bottleneck that impacts all of healthcare.

Clinicians are having to enter and request information inefficiently.

Currently, there is no approach for a clinician to validate and log a clinical procedure contemporaneously.

Documentation must be done after the fact and can take hours per day.

Clear Protocol


Clear Protocol® was specially designed to be used at the point of care, hands-free, in a practical way.

Users can select a procedure and validate it in real time.

Completed protocols are logged automatically.

In Use Today

Currently, the most effective solutions to avoid medical errors utilize a checklist, and then record the verification by manual data entry. But they share two limitations: (1) they are not integrated into the clinical care delivery, and therefore cause interruptions in workflow to manually enter data; and (2) they are not practical to implement permanently throughout a hospital.

Competitive Advantage

We are the first comprehensive patented solution that:

1. operates hands-free,
2. gives clinicians bedside access to the EHR, Rx and CPOE systems,
3. enables clinicians to validate and log clinical practice protocols (checklists) continuously and unobtrusively,
4. accepts any checklist used in health organizations.

Our solution leveraged existing, mature technology – voice recognition – already in use in 90% of hospitals and embedded in the leading EHR systems: Epic, Cerner, Allscripts, and MEDITECH.

The solution is Clear Protocol®, a patented software system that uses electronic wearables, is hands-free, and voice operated.

Two issued US Utility Patent 10,318,928B1. (2019), and 11,341,460 B2 (2022).

Go To Market

We plan to gain adoption by appealing directly to physicians as they experience the greatest pain points of wasted data entry time and potential malpractice liability.

Our Team

We have a multi-disciplinary team with the right skills and key insights to develop a system that will eliminate worker errors. We are system integrators who know more than just hardware and software. Our team has experience and degrees in nursing, PhDs in Healthcare Informatics, Computer Science, Engineering; Finance, Project Management,Corporate Law, Intellectual Property Law, and a passion for assistive technology –building businesses and authoring scientific research in this area over many years.

Use of Funds

The net proceeds will be used primarily for product development, testing with our doctor advisors, investor outreach, and marketing.


A “Top 100” US law firm, Sheppard Mullin, filed our patents, which were issued in 2019 and 2022.

UCLA computer science advised and programmed our working prototype.  

Since 2016, we have been collaborating with Dimitrios Zikos, Ph.D., Associate Professor, Health Administration Program, Director of Health Administration Division, Central Michigan University.

There are about twenty specialized experts who helped or are helping with development.

We have received two seed-funding rounds of capital, provided by Ashur Capital, LLC, led by Robert Gabriel, PhD. Ashur Capital has indicated a willingness to participate in subsequent funding rounds.

In July 2022 we hired Schlesinger Group, Baltimore to conduct a survey of nearly 200 doctors. Please see our “Market Validation” page.

We have connections to engineering talent, medical advisors, and legal advice both corporate and intellectual property.

We developed a demo prototype on hardware devices that were tested by our advisors (2022-23)

The company is currently pre-revenue, focused on developing the product.

Revenue Model

Recurring revenue will come from “per bed” or “per user” subscriptions. There will also be one-time setup and training fees.

Securities Offering

We are offering a 24-month convertible note with a 8% return plus discounts for early investors off of a $4,000,000 valuation. See the Offering Statement for complete offering details.

Clear Protocol Address